CA
NZ
UK
AU
IND
US
NewAmsterdam Pharma has received a positive CHMP opinion for Ubeslo® and Evlarco®, paving the way for potential commercialization in Europe. This milestone highlights the company's focus on addressing significant unmet needs in cardiovascular disease therapies, promising strong market potential for investors.[CTA: Subscribe to our …
MannKind Corp has entered into a private placement agreement that will generate $50 million for the company. This funding is aimed at meeting financial obligations linked to the recent FDA approval of Furoscix ReadyFlow™, thus strengthening its operational capacity.[CTA: Join our daily market newsletter]Key …
Regeneron shareholders who bought shares between Aug 1 2025 and May 15 2026 must act before Sep 14 2026 to join a securities class action, after the company’s Phase III trial missed its primary endpoint, causing a $45.41 (6.2%) slide and a later $68.57 …
Pediatrix Medical Group (NYSE: MD) has installed David Haddock as Executive Vice President, General Counsel and Secretary, marking its 11th leadership transition since mid‑2022. The move offers investors continuity in legal and administrative oversight as the stock, up over 23% this year, navigates a …
Sartorius Stedim Biotech S.A. reported a second-quarter earnings per share of $1.77, exceeding the expected $1.22, despite a 6.9% drop in share price. Investors reacted negatively as year-to-date share performance remains down significantly.[CTA: Join our daily market newsletter]Key HighlightsSartorius Stedim Biotech reported an earnings …
Willow Health Services has voluntarily discontinued its advertising claims for compounded semaglutide products following a regulatory challenge. This development could reshape investor confidence in compounded medications, particularly as the market grapples with the implications of regulatory actions on weight loss solutions.[CTA: Join our daily …
Vir Biotechnology (NASDAQ: VIR) announced that CFO Jason O’Byrne will depart on Aug 3 and senior vice president Brent Sabatini will assume interim principal financial officer duties. The transition matters because investors will assess whether the interim leader can preserve financial reporting quality while …
UBS Group AG has reiterated its stock rating for Tenet Healthcare following strong second-quarter earnings, with reported EPS exceeding expectations. This affirmation comes as UBS shares have shown notable performance year-to-date, indicating investor confidence in the sector's potential for growth.[CTA: Join our daily market …
Carrier Global appointed Neil Barua, President and CEO of PTC Inc., as an independent director effective July 24 2026, with a term ending at the 2027 annual meeting. Barua’s AI and digital‑transformation background bolsters board expertise in technology and compensation, a strategic gain for …
VivoSim Labs, Inc. reported stockholders’ equity of $(1.1 million), potentially risking its Nasdaq listing. The company has 45 calendar days to submit a compliance plan, impacting investor confidence significantly.[CTA: Join our daily market newsletter]Key HighlightsVivoSim Labs reported stockholders’ equity of $(1,099,000) as of March …
Please wait processing your request...